or Try an Advanced Search...

    Stage Renal Disease Stocks List

    Symbol Grade Name % Change
    AZN F Astrazeneca PLC 0.38
    BAX F Baxter International Inc. 0.48
    DVA D DaVita HealthCare Partners Inc. 1.27
    FMS D Fresenius Medical Care AG 1.13
    ARDX D Ardelyx, Inc. 3.75
    OPK C OPKO Health Inc. 0.00
    ATRA C Atara Biotherapeutics, Inc. 8.98
    PIRS A Pieris Pharmaceuticals, Inc. 0.29
    RMTI A Rockwell Medical, Inc. 3.84
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Medical Instruments & Supplies
    Related Stock Lists: End Stage Renal Disease Renal Disease Dialysis Kidney Disease Medicine Chronic Kidney Disease Hemodialysis Membrane Technology Clinical Medicine Kidney Dialysis Phosphates Renal Dialysis Asthma Biopharmaceutical Cancer Kidney Rockwell Medical Acid Chronic Obstructive Pulmonary Disease Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Stage Renal Disease stocks.

    Symbol Grade Name Weight
    OZEM D Roundhill GLP-1 & Weight Loss ETF 5.63
    THNR F Amplify Weight Loss Drug & Treatment ETF 5.34
    MEDX D Horizon Kinetics Medical ETF 5.15
    PPH D Market Vectors Pharmaceutical ETF 4.96
    IBBQ D Invesco Nasdaq Biotechnology ETF 4.6
    View all Stage Renal Disease ETFs...
    Compare ETFs
    Compare OZEM to MEDX Compare OZEM to PPH Compare OZEM to THNR

        Stage Renal Disease Stocks Recent News

        Date Stock Title
        Nov 1 FMS Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
        Nov 1 ARDX Q3 2024 Ardelyx Inc Earnings Call
        Nov 1 OPK Waters (WAT) Beats Q3 Earnings and Revenue Estimates
        Nov 1 ARDX Ardelyx Inc (ARDX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amidst ...
        Nov 1 AZN U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners
        Nov 1 ARDX Ardelyx, Inc. (ARDX) Q3 2024 Earnings Call Transcript
        Oct 31 ARDX Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics
        Oct 31 ARDX Ardelyx (ARDX) Reports Break-Even Earnings for Q3
        Oct 31 ARDX Ardelyx Beats Q3 Sales Estimates, Shares Climb
        Oct 31 ARDX Ardelyx: Q3 Earnings Snapshot
        Oct 31 ARDX Ardelyx GAAP EPS of $0.00 beats by $0.05, revenue of $98.24M beats by $11.6M
        Oct 31 ARDX Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
        Oct 31 AZN AstraZeneca Probe in China Adds to Concerns for Foreign Businesses
        Oct 31 FMS Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts
        Oct 31 AZN 3 Rock-Solid Dividend Stocks You Can Buy and Hold Forever
        Oct 31 DVA DaVita Third Quarter 2024 Earnings: EPS Misses Expectations
        Oct 31 AZN China Widens AstraZeneca Probe as Country Boss Investigated
        Oct 30 DVA Why DaVita Stock Withered on Wednesday
        Oct 30 ARDX Ardelyx Q3 2024 Earnings Preview
        Oct 30 AZN AstraZeneca executive under investigation by police in China
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Medical Instruments & Supplies
        Related Stock Lists: End Stage Renal Disease Renal Disease Dialysis Kidney Disease Medicine Chronic Kidney Disease Hemodialysis Membrane Technology Clinical Medicine Kidney Dialysis Phosphates Renal Dialysis Asthma Biopharmaceutical Cancer Kidney Rockwell Medical Acid Chronic Obstructive Pulmonary Disease Drugs
        Stage Renal Disease

        Stage Renal Disease (SRD) is a progressive condition in which the kidneys gradually lose their ability to filter waste and excess fluids from the body. It is the end stage of chronic kidney disease, and is also known as end-stage renal disease (ESRD). Symptoms of SRD include fatigue, nausea, vomiting, loss of appetite, and swelling in the hands and feet. Treatment for SRD includes dialysis or a kidney transplant.

        Browse All Tags